The DOI matches its Crossref record; 178 of the 179 references it cites were found in a registry or an index.
SOCS3, a Major Regulator of Infection and Inflammation
Open accessAbstract
In this review, we describe the role of suppressor of cytokine signaling-3 (SOCS3) in modulating the outcome of infections and autoimmune diseases as well as the underlying mechanisms. SOCS3 regulates cytokine or hormone signaling usually preventing, but in some cases aggravating, a variety of diseases. A main role of SOCS3 results from its binding to both the JAK kinase and the cytokine receptor, which results in the inhibition of STAT3 activation. Available data also indicate that SOCS3 can regulate signaling via other STATs than STAT3 and also controls cellular pathways unrelated to STAT activation. SOCS3 might either act directly by hampering JAK activation or by mediating the ubiquitination and subsequent proteasome degradation of the cytokine/growth factor/hormone receptor. Inflammation and infection stimulate SOCS3 expression in different myeloid and lymphoid cell populations as well as in diverse non-hematopoietic cells. The accumulated data suggest a relevant program coordinated by SOCS3 in different cell populations, devoted to the control of immune homeostasis in physiological and pathological conditions such as infection and autoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HDAC5 promotes the upregulation of Chemokine ligand 2 (CCL2) by inhibiting SOCS3, thereby recruiting CCR2+ macrophages [147].”
From Targeting KRAS mutant cancers: from druggable therapy to drug resistance (2022) · cites this paper as [147]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Suppressors of Cytokine Signaling 2 and 3 Diametrically Control Macrophage Polarization
Spence, S., Fitzsimons, A., Boyd, C. R., Kessler, J., Fitzgerald, D. C., Elliott, J., Gabhann, J. N., Smith, S., Sica, A., Hams, E., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.013 · Cited by 96
RetractedYaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“Binding to the cytokine activates the kinase function of JAK, a tyrosine kinase that binds to the receptor, which auto-phosphorylates itself, cross-phosphorylates a JAK molecule bound to the accompanying heterodimer chain of the cytokine receptor and also different tyrosine sites on the cytokine receptor (1).”
BackgroundNotch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Colman (2022) · doi:10.1073/pnas · Cited by 4,370
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 4×
“SOCS3 has been also suggested to inhibit IL-12-induced STAT4 activation by direct binding to IL-12Rβ2 (37), the IL-12R subunit that is not shared with the IL-23R.”
BackgroundInfluentialJournal of Biological Chemistry
Kurkinensp, M., CondongT, M. R., Blumberg, B., Barlow, D. P., Quiñones, S., Sausg, J., & Pihlajaniemisyy, T. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,427
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,287
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580
The JAK-STAT Pathway at Twenty
Stark, G. R., & Darnell, J. E., Jr. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.013 · Cited by 1,577
Regulation of JAK–STAT signalling in the immune system
Shuai, K., & Liu, B. (2003) · Nature reviews. Immunology · doi:10.1038/nri1226 · Cited by 1,410
A new protein containing an SH2 domain that inhibits JAK kinases
Endo, T. A., Masuhara, M., Yokouchi, M., Suzuki, R., Sakamoto, H., Mitsui, K., Matsumoto, A., Tanimura, S., Ohtsubo, M., Misawa, H., et al. (1997) · Nature · doi:10.1038/43213 · Cited by 1,408
STATs: Signal Transducers and Activators of Transcription
Ihle, J. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81277-5 · Cited by 1,381
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y., Spalding, C., Elloumi, H. Z., Paulson, M. L., et al. (2008) · Nature · doi:10.1038/nature06764 · Cited by 1,157
Structure and function of a new STAT-induced STAT inhibitor
Naka, T., Narazaki, M., Hirata, M., Matsumoto, T., Minamoto, S., Aono, A., Nishimoto, N., Kajita, T., Taga, T., Yoshizaki, K., et al. (1997) · Nature · doi:10.1038/43219 · Cited by 1,040
Identification of SOCS-3 as a Potential Mediator of Central Leptin Resistance
Bjørbæk, C., Elmquist, J. K., Frantz, J. D., Shoelson, S. E., & Flier, J. S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80062-3 · Cited by 1,014
Function of Mitochondrial Stat3 in Cellular Respiration
Wegrzyn, J., Potla, R., Chwae, Y.-J., Sepuri, N. B. V., Zhang, Q., Koeck, T., Derecka, M., Szczepanek, K., Szelag, M., Gornicka, A., et al. (2009) · Science · doi:10.1126/science.1164551 · Cited by 1,014
Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis
Balthasar, N., Coppari, R., McMinn, J., Liu, S. M., Lee, C. E., Tang, V., Kenny, C. D., McGovern, R. A., Chua, S. C., Elmquist, J. K., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.004 · Cited by 935
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904
SOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840
IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages
Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., et al. (2003) · Nature Immunology · doi:10.1038/ni938 · Cited by 771
Inhibition of Stat1-mediated gene activation by PIAS1
Liu, B., Liao, J., Rao, X., Kushner, S. A., Chung, C. D., Chang, D. D., & Shuai, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10626 · Cited by 765
Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., Hara, T., & Miyajima, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07281.x · Cited by 751
Twenty proteins containing a C-terminal SOCS box form five structural classes
Hilton, D. J., Richardson, R. T., Alexander, W. S., Viney, E. M., Willson, T. A., Sprigg, N. S., Starr, R., Nicholson, S. E., Metcalf, D., & Nicola, N. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.114 · Cited by 728
Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J. N., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1309 · Cited by 719
Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells
Chen, Z. J., Laurence, A. D. J., Kanno, Y., Pacher-Zavisin, M. C., Zhu, B., Tato, C. M., Yoshimura, A., Hennighausen, L. G., & O’Shea, J. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600666103 · Cited by 664
Mori, H., Hanada, R., Hanada, T., Aki, D., Mashima, R., Nishinakamura, H., Torisu, T., Chien, K. R., Yasukawa, H., & Yoshimura, A. (2004) · Nature Medicine · doi:10.1038/nm1071 · Cited by 651
Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.407 · Cited by 634
Zhang, J., Farley, A., Nicholson, S. E., Willson, T. A., Zugaro, L. M., Simpson, R. J., Moritz, R. L., Cary, D., Richardson, R. T., Hausmann, G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2071 · Cited by 626
Senn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., & Mooney, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210689200 · Cited by 620
Suppressors of cytokine signaling and immunity
Kubo, M., Hanada, T., & Yoshimura, A. (2003) · Nature Immunology · doi:10.1038/ni1012 · Cited by 617
Ogura, H., Murakami, M., Okuyama, Y., Tsuruoka, M., Kitabayashi, C., Kanamoto, M., Nishihara, M., Iwakura, Y., & Hirano, T. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.018 · Cited by 564
SOCS3 Mediates Feedback Inhibition of the Leptin Receptor via Tyr985
Bjørbæk, C., Lavery, H. J., Bates, S. H., Olson, R. K., Davis, S. M., Flier, J. S., & Myers, M. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007577200 · Cited by 537
Kawaguchi, T., Yoshida, T., Harada, M., Hisamoto, T., Nagao, Y., Ide, T., Taniguchi, E., Kumemura, H., Hanada, S., Maeyama, M., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63408-6 · Cited by 534
Gigantism in mice lacking suppressor of cytokine signalling-2
Metcalf, D., Greenhalgh, C. J., Viney, E. M., Willson, T. A., Starr, R., Nicola, N. A., Hilton, D. J., & Alexander, W. S. (2000) · Nature · doi:10.1038/35016611 · Cited by 490
Howard, J. K., Cave, B. J., Oksanen, L. J., Tzameli, I., Bjørbæk, C., & Flier, J. S. (2004) · Nature Medicine · doi:10.1038/nm1072 · Cited by 490
Wang, Y., He, F., Feng, F., Liu, X., Dong, G., Qin, H., Hu, X., Zheng, M., Liang, L., Feng, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0269 · Cited by 483
Tebbutt, N. C., Giraud, A. S., Inglese, M., Jenkins, B., Waring, P., Clay, F. J., Malki, S., Alderman, B. M., Grail, D., Hollande, F., et al. (2002) · Nature Medicine · doi:10.1038/nm763 · Cited by 474
Cis3/Socs3/Ssi3 Plays a Negative Regulatory Role in Stat3 Activation and Intestinal Inflammation
Suzuki, A., Hanada, T., Mitsuyama, K., Yoshida, T., Kamizono, S., Hoshino, T., Kubo, M., Yamashita, A., Okabe, M., Takeda, K., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.471 · Cited by 473
SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling
Emanuelli, B., Peraldi, P., Filloux, C., Sawka‐Verhelle, D., Hilton, D. J., & OBBERGHEN, E. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15985 · Cited by 468
Regulation of gene-activation pathways by PIAS proteins in the immune system
Shuai, K., & Liu, B. (2005) · Nature reviews. Immunology · doi:10.1038/nri1667 · Cited by 467
SOCS3 Deficiency Promotes M1 Macrophage Polarization and Inflammation
Qin, H., Holdbrooks, A. T., Liu, Y., Reynolds, S. L., Yanagisawa, L. L., & Benveniste, E. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201168 · Cited by 458
Nicholson, S. E., De Souza, D., Fabri, L. J., Corbin, J., Willson, T. A., Zhang, J.-G., Silva, A., Asimakis, M., Farley, A., Nash, A. D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100135197 · Cited by 456
SOCS3 regulates the plasticity of gp130 signaling
Lang, R., Pauleau, A.-L., Parganas, E., Takahashi, Y., Mages, J., Ihle, J. N., Rutschman, R., & Murray, P. J. (2003) · Nature Immunology · doi:10.1038/ni932 · Cited by 439
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis
Taleb, S., Romain, M., Ramkhelawon, B., Uyttenhove, C., Pasterkamp, G., Herbin, O., Esposito, B., Pérez, N., Yasukawa, H., Snick, J. V., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090545 · Cited by 426
Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1
Starr, R., Metcalf, D., Elefanty, A. G., Brysha, M., Willson, T. A., Nicola, N. A., Hilton, D. J., & Alexander, W. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14395 · Cited by 421
Cui, W., Liu, Y., Weinstein, J. S., Craft, J., & Kaech, S. M. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.017 · Cited by 410
Sasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., Kinjyo, I., Sasaki, M., Johnston, J. A., & Yoshimura, A. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00263.x · Cited by 398
Shouda, T., Yoshida, T., Hanada, T., Wakioka, T., Oishi, M., Miyoshi, K., Komiya, S., Kosai, K.-I., Hanakawa, Y., Hashimoto, K., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13568 · Cited by 394
Schmitz, J., Weissenbach, M., Haan, S., Heinrich, P. C., & Schaper, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12848 · Cited by 388
SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis
Marine, J.-C., McKay, C., Wang, D., Topham, D. J., Parganas, E., Nakajima, H., Pendeville, H., Yasukawa, H., Sasaki, A., Yoshimura, A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80049-5 · Cited by 372
Escary, J.-L., Perreau, J., Dumènil, D., Ezine, S., & Brûlet, P. (1993) · Nature · doi:10.1038/363361a0 · Cited by 363
SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses
Seki, Y.-I., Inoue, H., Nagata, N., Hayashi, K., Fukuyama, S., Matsumoto, K., Komine, O., Hamano, S., Himeno, K., Inagaki‐Ohara, K., et al. (2003) · Nature Medicine · doi:10.1038/nm896 · Cited by 361
Ernst, M., Najdovska, M., Grail, D., Lundgren–May, T., Büchert, M., Tye, H., Matthews, V. B., Armes, J. E., Bhathal, P. S., Hughes, N. R., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34944 · Cited by 349
STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor
Wang, Y., van Boxel-Dezaire, A. H. H., Cheon, H., Yang, J., & Stark, G. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315862110 · Cited by 327
IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology
Pellegrini, M., Calzascia, T., Toe, J. G., Preston, S., Lin, A. E., Elford, A. R., Shahinian, A., Lang, P. A., Lang, K. S., Morre, M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.01.011 · Cited by 317
Protein tyrosine phosphatases in the JAK/STAT pathway
Xu, D. (2008) · Frontiers in bioscience · doi:10.2741/3051 · Cited by 314
Jenkins, B. J., Grail, D., Nheu, T., Najdovska, M., Wang, B., Waring, P., Inglese, M., McLoughlin, R. M., Jones, S. A., Topley, N., et al. (2005) · Nature Medicine · doi:10.1038/nm1282 · Cited by 308
Kershaw, N. J., Murphy, J. M., Liau, N. P. D., Varghese, L. N., Laktyushin, A., Whitlock, E. L., Lucet, I. S., Nicola, N. A., & Babon, J. J. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2519 · Cited by 301
Canonical and non-canonical JAK–STAT signaling
Li, W. X. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.08.008 · Cited by 300
Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3
Roberts, A. W., Robb, L., Rakar, S., Hartley, L., Cluse, L., Nicola, N. A., Metcalf, D., Hilton, D. J., & Alexander, W. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161271798 · Cited by 300
SOCS3 Is a Critical Physiological Negative Regulator of G-CSF Signaling and Emergency Granulopoiesis
Croker, B. A., Metcalf, D., Robb, L., Wei, W., Mifsud, S., DiRago, L., Cluse, L. A., Sutherland, K. D., Hartley, L., Williams, E., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00022-6 · Cited by 285
Ohtani, T., Ishihara, K., Atsumi, T., Nishida, K., Kaneko, Y., Miyata, T., Itoh, S., Narimatsu, M., Maeda, H., Fukada, T., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80162-4 · Cited by 284
Influenza A Virus Inhibits Type I IFN Signaling via NF-κB-Dependent Induction of SOCS-3 Expression
Pauli, E.-K., Schmolke, M., Wolff, T., Viemann, D., Roth, J., Bode, J. G., & Ludwig, S. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000196 · Cited by 280
Babon, J. J., Kershaw, N. J., Murphy, J. M., Varghese, L. N., Laktyushin, A., Young, S. N., Lucet, I. S., Norton, R. S., & Nicola, N. A. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.015 · Cited by 279
Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis
Jo, D., Liu, D., Yao, S., Collins, R. D., & Hawiger, J. (2005) · Nature Medicine · doi:10.1038/nm1269 · Cited by 272
Qin, H., Yeh, W.-I., Sarno, P. D., Holdbrooks, A. T., Liu, Y., Muldowney, M., Reynolds, S. L., Yanagisawa, L. L., Fox, T. H., Park, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117218109 · Cited by 271
Nishihara, M., Ogura, H., Ueda, N., Tsuruoka, M., Kitabayashi, C., Tsuji, F., Aono, H., Ishihara, K., Huseby, E., Betz, U. A. K., et al. (2007) · International Immunology · doi:10.1093/intimm/dxm045 · Cited by 268
TGF-β Promotes Th17 Cell Development through Inhibition of SOCS3
Qin, H., Wang, L., Feng, T., Elson, C. O., Niyongere, S., Lee, S. J., Reynolds, S. L., Weaver, C. T., Roarty, K. P., Serra, R. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801986 · Cited by 253
Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production
Ogata, H., Chinen, T., Yoshida, T., Kinjyo, I., Takaesu, G., Shiraishi, H., Iida, M., Kobayashi, T., & Yoshimura, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209281 · Cited by 246
Han, W., & Lo, H. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.011 · Cited by 245
Cornejo, I., Andrini, O., Niemeyer, M. I., Marabolí, V., González-Nilo, F. D., Teulon, J., Sepúlveda, F. V., & Cid, L. P. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004402 · Cited by 245
Alvarez, J. V., Greulich, H. E., Sellers, W. R., Meyerson, M. M., & Frank, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3757 · Cited by 243
Saunders, B., Frank, A., Orme, I., & Cooper, A. (2000) · Infection and Immunity · doi:10.1128/iai.68.6.3322-3326.2000 · Cited by 240
Egwuagu, C. E., Yu, C., Zhang, M., Mahdi, R. M., Kim, S. J., & Gery, I. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3181 · Cited by 239
Yamamoto, M., Standley, D. M., Takashima, S., Saiga, H., Okuyama, M., Kayama, H., Kubo, E., Ito, H., Takaura, M., Matsuda, T., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20091703 · Cited by 236
SHP2 and SOCS3 Contribute to Tyr-759-dependent Attenuation of Interleukin-6 Signaling through gp130
Lehmann, U., Schmitz, J., Weissenbach, M., Sobota, R. M., Hörtner, M., Friederichs, K., Behrmann, I., Tsiaris, W., Sasaki, A., Schneider-Mergener, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210552200 · Cited by 236
Leaman, D. W., Pisharody, S., Flickinger, T. W., Commane, M., Schlessinger, J., Kerr, I. M., Levy, D. E., & Stark, G. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.369 · Cited by 226
Kinjyo, I., Inoue, H., Hamano, S., Fukuyama, S., Yoshimura, T., Koga, K., Takaki, H., Himeno, K., Takaesu, G., Kobayashi, T., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052333 · Cited by 225
Suppressor of Cytokine Signaling 3 Is a Physiological Regulator of Adipocyte Insulin Signaling
Shi, H., Tzameli, I., Bjørbæk, C., & Flier, J. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403886200 · Cited by 223
Orabona, C., Pallotta, M. T., Volpi, C., Fallarino, F., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Grohmann, U., & Puccetti, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810278105 · Cited by 214
Wong, P. K. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25660 · Cited by 214
STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers
Wang, X., Crowe, P. J., Goldstein, D., & Yang, J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1568 · Cited by 204
Gisterå, A., Robertson, A.-K. L., Andersson, J., Ketelhuth, D. F. J., Овчинникова, О. А., Nilsson, S. K., Lundberg, A. M., Li, M. O., Flavell, R. A., & Hansson, G. K. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006133 · Cited by 194
Tanaka, K., Ichiyama, K., Hashimoto, M., Yoshida, H., Takimoto, T., Takaesu, G., Torisu, T., Hanada, T., Yasukawa, H., Fukuyama, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3746 · Cited by 188
Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity
Wunderlich, C. M., Hövelmeyer, N., & Wunderlich, F. T. (2013) · JAK-STAT · doi:10.4161/jkst.23878 · Cited by 176
Braun, D. A., Fribourg, M., & Sealfon, S. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.386573 · Cited by 168 · cited 2×
“as the putative cause of SOCS3’s effect: the suppressive effect of IL-6 signaling on TNF and IL-12 secretion in absence of SOCS3 was explained to be due to a sustained STAT3 activation (101, 102).”
BackgroundCao, W., Yang, Y., Wang, Z., Liu, A., Fang, L., Wu, F., Hong, J., Shi, Y., Leung, S., Dong, C., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.06.011 · Cited by 168
Liu, Y., Stewart, K. N., Bishop, E., Marek, C. J., Kluth, D., Rees, A. J., & Wilson, H. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6270 · Cited by 168
Pothlichet, J., Chignard, M., & Si‐Tahar, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2034 · Cited by 165
Persico, M., Capasso, M., Persico, E., Svelto, M., Russo, R., Spano, D., Crocè, L. S., Mura, V. L., Moschella, F., Masutti, F., et al. (2007) · Hepatology · doi:10.1002/hep.21782 · Cited by 164
Babon, J. J., McManus, E. J., Yao, S., DeSouza, D. P., Mielke, L. A., Sprigg, N. S., Willson, T. A., Hilton, D. J., Nicola, N. A., Baca, M., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.024 · Cited by 163
Minamoto, S., Ikegame, K., Ueno, K., Narazaki, M., Naka, T., Yamamoto, H., Matsumoto, T., Saito, H., Hosoe, S., & Kishimoto, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7080 · Cited by 163
Frobøse, H., Rønn, S. G., Heding, P. E., Mendoza, H., Cohen, P., Mandrup-Poulsen, T. R., & Billestrup, N. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0301 · Cited by 161
Nguyen-Jackson, H., Panopoulos, A. D., Zhang, H., Li, H. S., & Watowich, S. S. (2010) · Blood · doi:10.1182/blood-2009-08-240317 · Cited by 151
Babon, J. J., Sabo, J. K., Zhang, J., Nicola, N. A., & Norton, R. S. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.024 · Cited by 146
Li, Y., Chu, N., Rostami, A. M., & Zhang, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1679 · Cited by 144
Schneider, R., Yaneva, T., Beauseigle, D., El‐Khoury, L., & Arbour, N. (2010) · European Journal of Immunology · doi:10.1002/eji.201040804 · Cited by 143
Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor
Eyckerman, S., Broekaert, D., Verhee, A., Vandekerckhove, J. S., & Tavernier, J. H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02205-5 · Cited by 143
IL-27 Suppresses CD28-Medicated IL-2 Production through Suppressor of Cytokine Signaling 3
Owaki, T., Asakawa, M., Kamiya, S., Takeda, K., Fukai, F., Mizuguchi, J., & Yoshimoto, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.2773 · Cited by 137
Miao, T., Wu, D., Zhang, Y., Bo, X., Subang, M. C., Wang, P., & Richardson, P. M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2160-06.2006 · Cited by 131
Yamamoto, K., Yamaguchi, M., Miyasaka, N., & Miura, O. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.140 · Cited by 131
The biology and mechanism of action of suppressor of cytokine signaling 3
Babon, J. J., & Nicola, N. A. (2012) · Growth Factors · doi:10.3109/08977194.2012.687375 · Cited by 129
Hörtner, M., Nielsch, U., Mayr, L. M., Johnston, J. A., Heinrich, P. C., & Haan, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1219 · Cited by 128
Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses During Atherosclerosis
Ortiz-Muñoz, G., Martı́n-Ventura, J. L., Hernández-Vargas, P., Mallavia, B., López-Parra, V., López‐Franco, Ó., Muñoz‐García, B., Fernández‐Vizarra, P., Ortega, L. M., Egido, J., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.173781 · Cited by 124
Wormald, S., Zhang, J.-G., Krebs, D. L., Mielke, L. A., Silver, J., Alexander, W. S., Speed, T. P., Nicola, N. A., & Hilton, D. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509595200 · Cited by 123 · cited 2×
“Interestingly, after the initial phosphorylation of STAT3 in response to IL-6 followed by a subsequent inhibition by SOCS3, a second wave of activation leads to the re-phosphorylation of STAT3 (101).”
BackgroundKimura, A., Kinjyo, I., Matsumura, Y., Mori, H., Mashima, R., Harada, M., Chien, K. R., Yasukawa, H., & Yoshimura, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c300496200 · Cited by 119
Matsumura, Y., Kobayashi, T., Ichiyama, K., Yoshida, R., Hashimoto, M., Takimoto, T., Tanaka, K., Chinen, T., Shichita, T., Wyss‐Coray, T., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2170 · Cited by 109
Ozaki, A., Seki, Y.-I., Fukushima, A., & Kubo, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5489 · Cited by 109
Akhtar, L. N., Qin, H., Muldowney, M., Yanagisawa, L. L., Kutsch, O., Clements, J. E., & Benveniste, E. N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903563 · Cited by 99
CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover
Orr, S. J., Morgan, N. M., Elliott, J., Burrows, J. F., Scott, C. J., McVicar, D. W., & Johnston, J. A. (2006) · Blood · doi:10.1182/blood-2006-05-023556 · Cited by 96
Auernhammer, C. J., Chesnokova, V., Bousquet, C., & Melmed, S. K. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.7.0140 · Cited by 95
Yeddula, N., & Balaji, K. N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709960200 · Cited by 93
Nair, S., Pandey, A. D., & Mukhopadhyay, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000773 · Cited by 92
Suppressor of cytokine signaling 3 controls lysosomal routing of G‐CSF receptor
Irandoust, M. I., Aarts, L. H. J., Roovers, O., Gits, J., Erkeland, S. J., & Touw, I. P. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601640 · Cited by 91
Hörtner, M., Nielsch, U., Mayr, L. M., Heinrich, P. C., & Haan, S. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02916.x · Cited by 88
Orabona, C., Belladonna, M. L., Vacca, C., Bianchi, R., Fallarino, F., Volpi, C., Gizzi, S., Fioretti, M. C., Grohmann, U., & Puccetti, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6582 · Cited by 88
McKay, B. R., Ogborn, D. I., Baker, J. M., Toth, K., Tarnopolsky, M. A., & Parise, G. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00305.2012 · Cited by 87
Persico, M., Capasso, M., Russo, R., Persico, E., Crocè, L. S., Tiribelli, C., & Iolascon, A. (2007) · Gut · doi:10.1136/gut.2007.129478 · Cited by 85
A Critical Role for SOCS3 in Innate Resistance to Toxoplasma gondii
Whitmarsh, R. J., Gray, C. M., Gregg, B., Christian, D. A., May, M. J., Murray, P. J., & Hunter, C. A. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.07.009 · Cited by 80
Emery, B., Cate, H. S., Marriott, M., Merson, T., Binder, M. D., Snell, C., Soo, P. Y., Murray, S., Croker, B., Zhang, J.-G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602574103 · Cited by 78
Jiang, C., Kim, J. H., Li, F., Qu, A., Gavrilova, O., Shah, Y. M., & Gonzalez, F. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.426338 · Cited by 78
Gisterå, A., Robertson, A.-K., Andersson, J., Ketelhuth, D. F. J., Овчинникова, О. А., Nilsson, S. K., Lundberg, A. M., Li, M. O., Flavell, R. A., & Hansson, G. K. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.233 · Cited by 78
Boyle, K., Egan, P. J., Rakar, S., Willson, T. A., Wicks, I. P., Metcalf, D., Hilton, D. J., Nicola, N. A., Alexander, W. S., Roberts, A. W., et al. (2007) · Blood · doi:10.1182/blood-2007-03-079178 · Cited by 74
Yoshikawa, T., Takata, A., Otsuka, M., Kishikawa, T., Kojima, K., Yoshida, H., & Koike, K. (2012) · Scientific Reports · doi:10.1038/srep00637 · Cited by 72
Oba, T., Yasukawa, H., Hoshijima, M., Sasaki, K., Futamata, N., Fukui, D., Mawatari, K., Nagata, T., Kyogoku, S., Ohshima, H., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.887 · Cited by 71
Yokota, S., Yokosawa, N., Okabayashi, T., Suzutani, T., & Fujii, N. (2005) · Virology · doi:10.1016/j.virol.2005.04.028 · Cited by 67
Sodenkamp, J., Waetzig, G. H., Scheller, J., Seegert, D., Grötzinger, J., Rose‐John, S., Ehlers, S., & Hölscher, C. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.01.015 · Cited by 66
Brender, C., Tannahill, G. M., Jenkins, B. J., Fletcher, J. G., Columbus, R., Saris, C. J. M., Ernst, M., Nicola, N. A., Hilton, D. J., Alexander, W. S., et al. (2007) · Blood · doi:10.1182/blood-2006-08-041541 · Cited by 65
SOCS3 Targets Siglec 7 for Proteasomal Degradation and Blocks Siglec 7-mediated Responses
Orr, S. J., Morgan, N. M., Buick, R. J., Boyd, C. R., Elliott, J., Burrows, J. F., Jefferies, C. A., Crocker, P. R., & Johnston, J. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600216200 · Cited by 64
Carow, B., Ye, X. Q., Gavier‐Widén, D., Bhuju, S., Oehlmann, W., Singh, M., Sköld, M., Ignatowicz, L., Yoshimura, A., Wigzell, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238287 · Cited by 63
Self-citationKim, K., Kim, K. H., & Cheong, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008649 · Cited by 62
Caruso, R., Stolfi, C., Sarra, M., Rizzo, A., Fantini, M. C., Pallone, F., MacDonald, T. T., & Monteleone, G. (2009) · Blood · doi:10.1182/blood-2008-08-172767 · Cited by 62
Structural Basis for Phosphotyrosine Recognition by Suppressor of Cytokine Signaling-3
Bergamin, E., Wu, J., & Hubbard, S. R. (2006) · Structure · doi:10.1016/j.str.2006.06.011 · Cited by 60
Masood, K. I., Rottenberg, M. E., Salahuddin, N., Irfan, M., Rao, N. A., Carow, B., Islam, M., Hussain, R., & Hasan, Z. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-13 · Cited by 58
Self-citationLee, J. E., Yang, Y., Liang, F., Gough, D. J., Levy, D. E., & Sehgal, P. B. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00379.2011 · Cited by 58
Kim, K., Lin, W., Tai, A. W., Shao, R., Weinberg, E. M., Borges, C. B. D. S., Bhan, A. K., Zheng, H., Kamegaya, Y., & Chung, R. T. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.021 · Cited by 57
IL‐6 promotes acute and chronic inflammatory disease in the absence of SOCS3
Croker, B. A., Kiu, H., Pellegrini, M., Toe, J. G., Preston, S., Metcalf, D., O’Donnell, J. A., Cengia, L. H., McArthur, K., Nicola, N. A., et al. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.29 · Cited by 53
Palanivel, R., Fullerton, M. D., Galić, S., Honeyman, J. E., Hewitt, K., Jørgensen, S. B., & Steinberg, G. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2665-3 · Cited by 53
Michaud, F., Coulombe, F., Gaudreault, É., Paquet‐Bouchard, C., Rola‐Pleszczynski, M., & Gosselin, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011908 · Cited by 52
Romain, M., Taleb, S., Dalloz, M., Ponnuswamy, P., Esposito, B., Pérez, N., Wang, Y., Yoshimura, A., Tedgui, A., & Mallat, Z. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300516 · Cited by 52
Funaoka, Y., Sakamoto, N., Suda, G., Itsui, Y., Nakagawa, M., Kakinuma, S., Watanabe, T., Mishima, K., Ueyama, M., Onozuka, I., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02583-10 · Cited by 51
Elevated Expression and Genetic Association Links the SOCS3 Gene to Atopic Dermatitis
Ekelund, E., Sääf, A. M., Tengvall-Linder, M., Melén, E., Link, J., Barker, J. N., Reynolds, N. J., Meggitt, S. J., Kere, J., Wahlgren, C., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/504272 · Cited by 51
SOCS3 promotes TLR4 response in macrophages by feedback inhibiting TGF-β1/Smad3 signaling
Liu, X., Zhang, Y., Yu, Y., Yang, X. Y., & Cao, X. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.08.018 · Cited by 50
Zhang, Z., Liu, Q., Che, Y., Yuan, X., Dai, L., Zeng, B., Jiao, G., Zhang, Y., Wu, X., Yu, Y., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2970 · Cited by 50
Hamanaka, I., Saito, Y., Yasukawa, H., Kishimoto, I., Kuwahara, K., Miyamoto, Y., Harada, M., Ogawa, E., Kajiyama, N., Takahashi, N., et al. (2001) · Circulation Research · doi:10.1161/hh0701.088512 · Cited by 49
Robb, L. G., Boyle, K., Rakar, S., Hartley, L., Lochland, J., Roberts, A. W., Alexander, W. S., & Metcalf, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508023102 · Cited by 48
TGF-β-induced SOCS3 expression augments TNF-α-induced osteoclast formation
Lovibond, A. C., Haque, S. J., Chambers, T. J., & Fox, S. W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.068 · Cited by 48
Magrangeas, F., Boisteau, O., DENIS, S., Jacques, Y., & Minvielle, S. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530223 · Cited by 48
Hashimoto, K., Ishibashi, K., Ishioka, K., Zhao, D., Sato, M., Ohara, S., Abe, Y., Kawasaki, Y., Sato, Y., Yokota, S., et al. (2009) · Virology · doi:10.1016/j.virol.2009.06.026 · Cited by 46
Yan, C., Ward, P. A., Wang, X., & Gao, H. (2013) · The FASEB Journal · doi:10.1096/fj.12-225797 · Cited by 46
Suppressors of Cytokine Signaling 2 and 3 Diametrically Control Macrophage Polarization
Spence, S., Fitzsimons, A., Boyd, C. R., Kessler, J., Fitzgerald, D. C., Elliott, J., Gabhann, J. N., Smith, S., Sica, A., Hams, E., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.016 · Cited by 45
Shouda, T., Yoshida, T., Hanada, T., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113568 · Cited by 44
IL-6 Mediates the Susceptibility of Glycoprotein 130 Hypermorphs to Toxoplasma gondii
Silver, J. S., Stumhofer, J. S., Passos, S., Ernst, M., & Hunter, C. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004144 · Cited by 42
Carow, B., Reuschl, A., Gavier‐Widén, D., Jenkins, B. J., Ernst, M., Yoshimura, A., Chambers, B. J., & Rottenberg, M. E. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003442 · Cited by 42
Self-citationSOCS3 regulates graft-versus-host disease
Hill, G. R., Kuns, R. D., Raffelt, N. C., Don, A. L. J., Olver, S. D., Markey, K. A., Wilson, Y. A., Tocker, J. E., Alexander, W. S., Clouston, A. D., et al. (2010) · Blood · doi:10.1182/blood-2009-12-259598 · Cited by 40
Bixler, S. L., Utay, N. S., Douek, D. C., & Mattapallil, J. J. (2013) · Journal of Virology · doi:10.1128/jvi.00600-13 · Cited by 37
Croker, B. A., Mielke, L. A., Wormald, S., Metcalf, D., Kiu, H., Alexander, W. S., Hilton, D. J., & Roberts, A. W. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.02.008 · Cited by 34
Fletcher, T. C., DiGiandomenico, A., & Hawiger, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095216 · Cited by 33
Moriwaki, A., Inoue, H., Nakano, T., Matsunaga, Y., Matsuno, Y., Matsumoto, T., Fukuyama, S., Kan‐o, K., Matsumoto, K., Tsuda, M., et al. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0051oc · Cited by 33
Veenbergen, S., Bennink, M. B., de Hooge, A. S. K., Arntz, O. J., Smeets, R. L., van den Berg, W. B., & van de Loo, F. A. J. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24072 · Cited by 31
Overexpression of the suppressor of cytokine signalling 3 (SOCS3) in severe atopic dermatitis.
Horiuchi, Y., Bae, S.-J., & Katayama, I. (2006) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2005.01979.x · Cited by 25
Auernhammer, C. J. (1998) · Molecular Endocrinology · doi:10.1210/me.12.7.954 · Cited by 22
gp130 on macrophages/granulocytes modulates inflammation during experimental tuberculosis
Sodenkamp, J., Behrends, J., Förster, I., Müller, W., Ehlers, S., & Hölscher, C. (2010) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.10.010 · Cited by 18
Nakaya, M., Hamano, S., Kawasumi, M., Yoshida, H., Yoshimura, A., & Kobayashi, T. (2011) · International Immunology · doi:10.1093/intimm/dxq472 · Cited by 17
Guidelines for the management of Irritable Bowel Syndrome
Spiller, R., Aziz, Q., Creed, F. H., Emmanuel, A. V., Houghton, L. A., Hungin, A. P., Jones, R., Kumar, D., Rubin, G. P., Trudgill, N., et al. (2007) · Durham Research Online (Durham University) · doi:10.1136/gut.2007 · Cited by 17
Gu, H., Liu, L., Ma, S., Liu, Y., Ren, Y., Zhai, L., Yu, F., An, L., & Yang, J. (2009) · Endocrine · doi:10.1007/s12020-009-9253-4 · Cited by 15
Erratum To: Suppressor of cytokine signaling 3 controls lysosomal routing of G‐CSF receptor
Irandoust, M. I., Aarts, L. H. J., Roovers, O., Gits, J., Erkeland, S. J., & Touw, I. P. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601709 · Cited by 13
Levy, D. E., & Marié, I. J. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.003 · Cited by 12
Emery, B., Butzkueven, H., Snell, C. E., Binder, M. D., & Kilpatrick, T. J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.022 · Cited by 11
Perturbed thymopoiesis in vitro in the absence of suppressor of cytokine signalling 1 and 3
McQuilten, H. A., Izon, D. J., Chong, M. M. W., Curtis, D. J., Roberts, A. W., Kay, T. W. H., Hilton, D. J., Alexander, W. S., & Starr, R. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.01.024 · Cited by 10
“Suppressor of Cytokine Signalling” Molecules in Infection and Inflammation
Carow, B., & Martin, E. (2012) · InTech eBooks · doi:10.5772/25986 · Cited by 4
Self-citation(2014) · Institutional Repository University of Antioquia (University of Antioquia) · doi:10.1371/journal.pone
Flagged first, then by citations
1 of the 179 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Li, L., Yu, R., Cai, T., Chen, Z., Lan, M., Zou, T., Wang, B., Wang, Q., Zhao, Y., & Cai, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106939 · Cited by 397
Macrophage and Fibroblast Interactions in Biomaterial‐Mediated Fibrosis
Witherel, C. E., Abebayehu, D., Barker, T. H., & Spiller, K. L. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801451 · Cited by 374
DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases
WHI-EMPC Investigators, Ligthart, S., Disease, C. E. O. C. H., Marzi, C., Aslibekyan, S. W., Mendelson, M., Conneely, K. N., Tanaka, T., Colicino, E., Waite, L. L., et al. (2016) · Genome biology · doi:10.1186/s13059-016-1119-5 · Cited by 317
“The gene product of SOCS3, suppressor of cytokine signaling 3, plays a pivotal role in the innate immune system as a regulator of cytokine signaling [11].”
BackgroundT cell exhaustion during persistent viral infections
Kahan, S. M., Wherry, E. J., & Zajac, A. J. (2015) · Virology · doi:10.1016/j.virol.2014.12.033 · Cited by 327
Single‐cell transcriptomics reveals distinct inflammation‐induced microglia signatures
Sousa, C., Golebiewska, A., Poovathingal, S. K., Kaoma, T., Pires‐Afonso, Y., Martina, S., Coowar, D., Azuaje, F., Skupin, A., Balling, R., et al. (2018) · The EMBO Reports · doi:10.15252/embr.201846171 · Cited by 281
“Specifically, STAT3 and suppressor of cytokine signalling 3 (SOCS3) regulate inflammatory responses [54].”
Metadata
- Authors
- Carow, B., & Rottenberg, M. E.
- Affiliations
- Karolinska Institutet (SE)
- Corresponding author
- Carow, Berit
- ORCID
- Carow, Berit
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2014
- Volume
- 5
- Pages
- 58-58
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC3928676
- OpenAlex
- W2140013858
- Cited by
- 555
- References
- 179
- Citations by year
- 2026: 31 · 2025: 55 · 2024: 65 · 2023: 71 · 2022: 64 · 2021: 58 · 2020: 43 · 2019: 52 · 2018: 31 · 2017: 25 · 2016: 27 · 2015: 24 · 2014: 9
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- SOCS3, suppressor of cytokine signaling, infection, inflammation, autoimmune disease, STAT3 activation, JAK kinases, cytokine signaling, receptor ubiquitination, proteasomal degradation, immune homeostasis, myeloid cells, lymphoid cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review